Literature DB >> 3499329

Comparative pharmacology of EDRF and nitric oxide on vascular strips.

P J Hutchinson1, R M Palmer, S Moncada.   

Abstract

The comparative pharmacology of endothelium-derived relaxing factor (EDRF) and nitric oxide (NO) was studied on isolated strips of rabbit aorta. Both compounds were equally unstable. The relaxations of the bioassay tissues induced by EDRF released by bradykinin (3-100 nM) and by NO (4-134 nM) were indistinguishable. The stability of both compounds was increased to a similar extent by infusions of superoxide dismutase (SOD; 15 U.ml-1) or of cytochrome c (40 microM). The relaxations induced by EDRF and NO were inhibited to similar extents by infusions of Fe2+, hydroquinone and pyrogallol, an effect attenuated by a concomitant infusion of SOD or cytochrome c. The relaxations induced by both compounds were also inhibited by haemoglobin, however, this effect was unaltered by concomitant infusion of SOD. These data indicate that EDRF and NO have identical biological activity, stability and susceptibility to inactivation by superoxide anions and haemoglobin, providing further confirmation that EDRF is NO.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499329     DOI: 10.1016/0014-2999(87)90563-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  19 in total

1.  Effects of amyl nitrite on circulation, respiration and blood homoeostasis in cyanide poisoning.

Authors:  R Klimmek; C Krettek
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

Review 2.  Transient Receptor Potential Channels and Endothelial Cell Calcium Signaling.

Authors:  Pratish Thakore; Scott Earley
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

3.  Dorzolamide-induced relaxation of isolated rabbit ciliary arteries mediated by inhibition of extracellular calcium influx.

Authors:  Yaru Dong; Yu Sawada; Jizhe Cui; Masahiro Hayakawa; Dai Ogino; Makoto Ishikawa; Takeshi Yoshitomi
Journal:  Jpn J Ophthalmol       Date:  2016-01-12       Impact factor: 2.447

4.  Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?

Authors:  Undurti N Das
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-02       Impact factor: 5.555

5.  Evidence of partially preserved endothelial dilator function in diseased coronary arteries.

Authors:  D Tousoulis; C Tentolouris; T Crake; C Stefanadis; P Toutouzas; G Davies
Journal:  Heart       Date:  1999-10       Impact factor: 5.994

6.  Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation.

Authors:  B J Whittle; J Lopez-Belmonte; D D Rees
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

7.  Tributyltin chloride disrupts aortic vascular reactivity and increases reactive oxygen species production in female rats.

Authors:  Carolina Falcão Ximenes; Samya Mere Lima Rodrigues; Priscila Lang Podratz; Eduardo Merlo; Julia Fernandez Puñal de Araújo; Lívia Carla Melo Rodrigues; Juliana Barbosa Coitinho; Dalton Valentim Vassallo; Jones Bernardes Graceli; Ivanita Stefanon
Journal:  Environ Sci Pollut Res Int       Date:  2017-09-13       Impact factor: 4.223

8.  Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats.

Authors:  M S Chintala; P J Chiu; S Vemulapalli; R W Watkins; E J Sybertz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

9.  The effects of endothelin-1 and NG-nitro-L-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus.

Authors:  R J Kiff; S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

10.  Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor.

Authors:  A Zembowicz; T A Swierkosz; G J Southan; M Hecker; J R Vane
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.